RNAi-based therapeutics targeting survivin and PLK1 for treatment of bladder cancer.
暂无分享，去创建一个
B. Polisky | M. Templin | P. Harvie | N. Vaish | Feng Chen | S. Seth | K. Fosnaugh | Yan Liu | R. Adami | Tod Brown | Yan Chen | Rachel E. Johns | G. Severson | P. Charmley | M. Houston | A. So | Y. Matsui | M. Mccutcheon | I. Maciągiewicz | S. Bell | Akihide Takagi | Tianying Zhu | R. Fam | E. Kwang | K. Farber